Rapid Infection Diagnostics Appoints Mario Savarese to Strategic Advisory Board
CALGARY, AB, Oct. 21, 2026 /PRNewswire/ -- Rapid Infection Diagnostics Inc. (RID), a Canadian life sciences company specializing in the use of metabolomics for rapid infectious diseases diagnosis, announced today the appointment of Mario Savarese to its Strategic Advisory Board. Former...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.